Schott: Expansion Of Syringe Manufacturing Capacity®

Date: 17 August 2007
Source: Schott

Date: 17 August 2007

SCHOTT forma vitrum has tripled its production capacity with glass and polymer syringes in St. Gallen, Switzerland.

The international manufacturer of pharmaceutical packaging has invested around 20 million euros to glass forming, infrastructure, clean rooms and WFI facilities (water for injection purposes).The new production facilities are based on state-of-the-art technology. In addition, several accompanying measures were taken to further improve the flow of goods and optimize customer service following expansion.

600450 Schott: Expansion Of Syringe Manufacturing Capacity® glassonweb.com

See more news about:

Others also read

Effective January 1, 2025, Dr. Torsten Derr will take the helm of SCHOTT AG as CEO. He will succeed Dr. Frank Heinricht, who led the group successfully for eleven years and will retire on December 31, 2024.
Dr. Frank Heinricht to retire as CEO of SCHOTT AG after 11 years of transformative leadership; Dr. Torsten Derr named successor
Awarded for the 18th time, this year’s Otto Schott Research Award goes to Prof. Setsuhisa Tanabe from Kyoto University in Japan.
The Story of LineScanner installation for visual defect detection at the Home Appliance Division at SCHOTT Flat Glass CR, in Valasske Mezirici, Czech Republic.
This year's Otto Schott Research Award went to two European researchers: Professor Alicia Durán from the Spanish Research Council (CSIC) in Madrid, Spain, and Professor Daniel Neuville from the Institut de Physique du Globe de Paris at the University of Paris.
SCHOTT is introducing a new, innovative portfolio of structured glass substrates that offers highly accurate and versatile features: FLEXINITY™.

Add new comment